Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Abstract

Evidence for peroxidase-mediated metabolism of cyclophosphamide.

S Kanekal and J P Kehrer
Drug Metabolism and Disposition January 1993, 21 (1) 37-42;
S Kanekal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J P Kehrer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Lung and bladder injury are side-effects of chemotherapy with cyclophosphamide (CP). Although the mixed-function oxidases are known to metabolize CP to reactive species, inhibitors of these enzymes have no significant effect on therapeutic activity or lung toxicity in vivo. In contrast, inhibitors of prostaglandin H synthase (PHS) can significantly decrease CP-induced lung injury. The current studies examined whether peroxidases can bioactivate CP in vitro. A mixture of 14C (ring) and 3H (side chain)-labeled CP (0.25-2 mM) was incubated with fresh lung and liver microsomes, horseradish peroxidase, or purified PHS using H2O2 or arachidonate as cosubstrates. All systems showed irreversible binding of CP-derived radioactivity to protein, increases in oxygen consumption, and generation of polar metabolites, including acrolein. Arachidonate-catalyzed binding of CP-derived radioactivity to fresh lung or liver microsomes, as well as H2O2 or arachidonate-supported generation of polar metabolites by purified PHS, was maximal by 2 min. In contrast, NADPH-catalyzed microsomal binding was linear for 30 min. This is consistent with the rapid self-inactivation of PHS in vitro. Arachidonate-catalyzed binding of CP-derived radioactivity to pulmonary microsomes was greater than liver, whereas the converse was true with NADPH. Incubation of 0.5 to 4 mM CP with PHS and arachidonate resulted in concentration-dependent increases in prostaglandin E2 synthesis. One mM H2O2 generated more polar metabolites from CP than 0.3 mM arachidonate when incubated with 100 units of purified PHS (10 +/- 2 and 4 +/- 1.5 nmol in 2 min, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 21, Issue 1
1 Jan 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evidence for peroxidase-mediated metabolism of cyclophosphamide.
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract

Evidence for peroxidase-mediated metabolism of cyclophosphamide.

S Kanekal and J P Kehrer
Drug Metabolism and Disposition January 1, 1993, 21 (1) 37-42;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Abstract

Evidence for peroxidase-mediated metabolism of cyclophosphamide.

S Kanekal and J P Kehrer
Drug Metabolism and Disposition January 1, 1993, 21 (1) 37-42;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics